Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Replimune Group Inc

REPL
Current price
12.21 USD -0.52 USD (-4.08%)
Last closed 12.7 USD
ISIN US76029N1063
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 813 024 640 USD
Yield for 12 month +5.81 %
1Y
3Y
5Y
10Y
15Y
REPL
21.11.2021 - 28.11.2021

Replimune Group, Inc., a clinical-stage biotechnology company, focuses on the development of oncolytic immunotherapies to treat cancer. The company's proprietary tumor-directed oncolytic immunotherapy product candidates are designed and intended to activate the immune system against cancer. Its lead product candidate is RP1, a selectively replicating version of HSV-1 that expresses GALV-GP R(-) and human GM-CSF, which is in Phase I/II clinical trials for a range of solid tumors. The company is also developing RP2, which is in Phase I clinical trials to express an anti-CTLA-4 antibody-like protein to block the inhibition of the immune response otherwise caused by CTLA-4; and RP3 that is in Phase I clinical trial to express immune-activating proteins that stimulate T cells. Replimune Group, Inc. was founded in 2015 and is headquartered in Woburn, Massachusetts. Address: 500 Unicorn Park Drive, Woburn, MA, United States, 01801

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

15.29 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

+4 042 000 USD

Current Year

-2 655 000 USD

Last Year

-2 447 000 USD

Current Quarter

-736 000 USD

Last Quarter

+3 387 000 USD

Key Figures REPL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -231 756 992 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -25.74 %
PEG Ratio
Return On Equity TTM -46.79 %
Wall Street Target Price 15.29 USD
Revenue TTM
Book Value 6.24 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -3.27 USD
Diluted Eps TTM -3.27 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics REPL

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History REPL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation REPL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -0.2383
Price Book MRQ 1.9065

Financials REPL

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators REPL

For 52 weeks

4.92 USD 12.86 USD
50 Day MA 11.14 USD
Shares Short Prior Month 6 067 342
200 Day MA 8.83 USD
Short Ratio 7.92
Shares Short 7 163 072
Short Percent 15.19 %